US regulators have blocked the $580m acquisition of a semiconductor test equipment maker by a state-backed Chinese fund in the latest deal to be halted amid heightened scrutiny of Chinese investments under Donald Trump.

美国监管机构阻止了一家由中国政府支持的基金以5.8亿美元收购美国一家半导体测试设备商的交易。这是唐纳德•特朗普(Donald Trump)主政后加强对中国投资审查力度导致的最新一起被否决交易。

Massachusetts-based Xcerra said on Thursday that it had agreed with Hubei Xinyan Equity Investment Partnership to terminate the merger agreement.

总部位于马萨诸塞州的Xcerra周四表示，它已与湖北鑫炎股权投资合伙企业(Hubei Xinyan Equity Investment Partnership)达成一致，将终止之前的合并协议。

“Despite our best efforts to secure approval, it has become evident that CFIUS will not clear this transaction and we and Xinyan have mutually decided to terminate our merger agreement,” said Xcerra chief executive Dave Tacelli.

“尽管我们为获得批准已尽了最大努力，但美国外国投资委员会(Cfius)显然将不会为这笔交易放行，我们和湖北鑫炎已共同决定终止我们的合并协议，”Xcerra首席执行官戴夫•塔切利(Dave Tacelli)说。

The US has a longstanding sensitivity about Chinese investments in the country’s semiconductor sector. Cfius last September blocked the $1.3bn acquisition of Lattice Semiconductor by a group of investors that included state-controlled China Venture Capital Fund on national security grounds.

长期以来，美国对中国企业对美国半导体行业的投资很敏感。去年9月，Cfius阻止了几家投资机构以13亿美元收购莱迪思半导体(Lattice Semiconductor)的交易，投资机构之一是国有的中国创业投资基金(China Venture Capital Fund)。

A growing number of Chinese investments targeting US companies have stalled owing to a slowdown in Washington’s national security review process and as trade tensions bubble between Beijing and the Trump administration.

由于美国的国家安全审查程序变慢，以及美中两国政府之间的贸易紧张，越来越多由中企投资美企的项目陷入了停滞。

Xcerra said in April 2017 it had agreed to be acquired for approximately $580m by Unic Capital Management, a subsidiary of state-backed Sino IC Capital and Hubei Xinyan.

Xcerra在2017年4月表示，它已同意中青芯鑫(Unic Capital Management)和湖北鑫炎以约5.8亿美元的价格收购自己。中青芯鑫是中国政府支持的华芯投资(Sino IC Capital)的子公司。